Patent Assignment
Reel/Frame 066181/0563
Assignment of Assignor's Interest
Recorded: 2024-01-19
Pages: 5
Assignor
SCOTT, DAVID WAYNE
Executed: 2023-12-08
Assignee
BRIDGEBIO GENE THERAPY RESEARCH, INC.
1001 WILLIAM MOORE DRIVE, SUITE 100, RALEIGH, NORTH CAROLINA, 27606
Covered Property
(1)
Gene Therapy for Tuberous Sclerosis
Application:
18/570,040 →
Publication:
US 2024/0261439
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jun 28, 2024
From: BRIDGEBIO PHARMA, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION
Reel/Frame 067870/0874 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0120 →